Update on clinical trials in home mechanical ventilation

Area of Science:

• Pulmonology and Respiratory Medicine
• Critical Care Medicine
• Sleep Medicine

Background:

• Home mechanical ventilation (HMV) is increasingly used for respiratory failure in conditions like COPD, NMD, and obesity.
• Recent data provides guidance on patient selection and optimizing sleep-disordered breathing management with HMV.
• Conflicting evidence exists regarding HMV efficacy in COPD, necessitating critical review.

Purpose of the Study:

• To critically review recent advances in sleep-disordered breathing and HMV.
• To analyze conflicting data on HMV in COPD and its implications for clinical practice.
• To evaluate the role of NIV in NMD and its potential benefits and risks.

Main Methods:

• Critical appraisal of recent clinical trial data and published literature on HMV and NIV.
• Comparative analysis of studies investigating HMV in stable versus post-exacerbation COPD.
• Review of evidence for diaphragm pacing and advanced ventilator technologies.

Main Results:

• HMV demonstrates a mortality benefit in stable chronic hypercapnic COPD but not in post-exacerbation COPD.
• Non-invasive ventilation (NIV) remains crucial for NMD, with diaphragm pacing showing potential harm.
• Advanced ventilator technologies show equivalence to standard NIV, with potential adherence benefits.
• The SERVE-HF trial indicated no benefit and potential harm from NIV in heart failure-related sleep-disordered breathing.

Conclusions:

• HMV application requires careful patient selection, particularly in COPD.
• NIV is essential for NMD, but its use in heart failure warrants caution.
• Continued research is needed to align technological advancements with robust clinical evidence for HMV and NIV.